The protective effects of Ninjin’yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The protective effects of Ninjin’yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse ; volume:78 ; number:3 ; day:18 ; month:3 ; year:2024 ; pages:514-524 ; date:6.2024
Journal of natural medicines ; 78, Heft 3 (18.3.2024), 514-524, 6.2024
- Urheber
-
Takano, Kyohei
Kaneda, Marisa
Aoki, Yayoi
Fujita, Nina
Chiba, Shigeki
Michihara, Seiwa
Han, Li-Kun
Takahashi, Ryuji
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11418-024-01786-2
- URN
-
urn:nbn:de:101:1-2407290927369.793587999458
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Takano, Kyohei
- Kaneda, Marisa
- Aoki, Yayoi
- Fujita, Nina
- Chiba, Shigeki
- Michihara, Seiwa
- Han, Li-Kun
- Takahashi, Ryuji
- SpringerLink (Online service)
Ähnliche Objekte (12)
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Non-alcoholic steatohepatitis in pregnancy: a case report
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Non-alcoholic steatohepatitis in pregnancy: a case report
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Non-alcoholic steatohepatitis in pregnancy: a case report
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma